专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明专利

AU2003200223B2 Transferring materials into cells using resorbable silicon 未知
公开(公告)号：AU2003200223B2
公开(公告)日：2005-05-05
申请号：AU2003200223
申请日：2003-01-24
申请人： PSIMEDICA LTD
发明人： CANHAM LEIGH TREVOR
IPC分类号： C12M003/00 , C12N015/87 , C12N015/89

82. 发明专利

ES2222704T3 IMPLANTES PARA ADMINISTRAR SUSTANCIAS Y METODOS DE PRODUCIR IMPLANTES. 未知
公开(公告)号：ES2222704T3
公开(公告)日：2005-02-01
申请号：ES99918102
申请日：1999-04-16
申请人： PSIMEDICA LTD
发明人： CANHAM LEIGH TREVOR , BARRETT CHRISTOPHER PAUL , BOWDITCH ANDREW PAUL , COX TIMOTHY INGRAM , WRIGHT PETER JOHN
IPC分类号： A61K9/00 , A61K31/00 , A61K33/00 , A61K47/02 , A61K47/34 , A61L27/00
摘要： Implante de silicio, que comprende silicio poroso, reabsorbible, semiconductor y una sustancia beneficiosa; caracterizado porque la estructura del silicio reabsorbible es tal que el silicio reabsorbible es compatible con el tejido, y porque la sustancia beneficiosa se ha asociado con el silicio reabsorbible compatible con el tejido.

83. 发明专利

AU2001278602B2 Dermatological composition 未知
公开(公告)号：AU2001278602B2
公开(公告)日：2004-12-02
申请号：AU2001278602
申请日：2001-08-15
申请人： PSIMEDICA LTD
发明人： CANHAM LEIGH TREVOR , ASTON ROGER
IPC分类号： A61K47/02 , A61K8/00 , A61K8/19 , A61K8/25 , A61K8/30 , A61K33/00 , A61K33/08 , A61P17/00 , A61P17/02 , A61P17/06 , A61P17/08 , A61P17/10 , A61P17/14 , A61P17/16 , A61P39/00 , A61Q1/00 , A61Q1/02 , A61Q1/04 , A61Q3/02 , A61Q17/04 , A61Q19/00 , A61K007/42 , A61K033/00 , A61K007/48
摘要： Dermatological methods of cosmetic, therapeutic, prophylactic, and/or diagnostic treatment by topically applying compositions comprising a multiplicity of particles, at least one of the particles comprising porous and/or polycrystalline silicon. Included are methods and compositions for sun protection applications. The use of porous silicon, polycrystalline silicon, and porous silicon oxide mirrors is disclosed.

84. 发明专利

GB0420676D0 Medical device 未知
公开(公告)号：GB0420676D0
公开(公告)日：2004-10-20
申请号：GB0420676
申请日：2004-09-17
申请人： PSIMEDICA LTD
IPC分类号： A61M5/32
摘要： The present invention relates to a substance delivery device comprising: (a) an electronic component, (b) a carrier component, and (c) a beneficial substance, the electronic component comprising: (i) a timer means for generating a carrier activation electrical signal that is time dependent; (ii) an electronic carrier activation means for releasing the beneficial substance in response to the carrier activation electrical signal; (iii) a power supply; and (iv) a substance delivery device activation means, for activating the device, having a construction such that once the substance delivery device is activated the electronic carrier activation means releases the beneficial substance in response to the carrier activation electrical signal. The substance delivery device is of particular value in the treatment of circadian, infradian, or ultradian cycle conditions.

86. 发明专利

DE60008517D1 未知
公开(公告)号：DE60008517D1
公开(公告)日：2004-04-01
申请号：DE60008517
申请日：2000-04-27
申请人： PSIMEDICA LTD
发明人： CANHAM TREVOR , BARRETT PAUL
IPC分类号： A61B17/00 , A61L27/02 , A61L31/00 , A61L31/02 , A61N5/06 , H01M14/00
摘要： Biomaterial comprising derivatized porous silicon is described. Derivatization of the porous silicon has been found to increase its stability. The porous silicon is preferably derivatized by a technique that does not involve oxidation of the silicon, e.g. by hydrosilylation. The derivatized porous silicon is stable to boiling in aerated water for preferably at least two hours. The derivatized porous silicon is preferably at least substantially stable to boiling in aerated basic solutions of aqueous KOH (pH 10) and solutions of 25% EtOH/75% aqueous KOH (pH 10) for one hour. The corrosion rate of the derivatized porous silicon material in simulated human plasma, is a factor of at least two orders of magnitude lower than underivatized porous silicon. The porosity of the derivatized porous silicon is preferably least 5%. Devices comprising the derivatized porous silicon are also described. These include immunoisolation devices, biobattery devices, and optical devices.

87. 发明专利

NZ519328A Orally administrable pharmaceutical product and method of fabrication therefor 未知
公开(公告)号：NZ519328A
公开(公告)日：2003-11-28
申请号：NZ51932800
申请日：2000-11-20
申请人： PSIMEDICA LTD
发明人： CANHAM LEIGH TREVOR , WARD MICHAEL CHARLES LESLIE
IPC分类号： A61J3/07 , A61J7/04 , A61K9/20 , A61K9/48
摘要： An orally administrable pharmaceutical product comprises an information carrier having a form and composition such that information is recorded by the carrier; wherein the information carrier comprises a resistant material that is resistant to the gastric environment. The information carrier can be a semiconductor or a fluorescent or photoluminescent material.

88. 发明专利

DE69902794D1 未知
公开(公告)号：DE69902794D1
公开(公告)日：2002-10-10
申请号：DE69902794
申请日：1999-07-22
申请人： PSIMEDICA LTD
发明人： CANHAM TREVOR
IPC分类号： C12N15/87 , C12M1/00 , C12M3/00 , C12N1/00 , C12N5/00 , C12N15/09 , C12N15/89
摘要： The present invention concerns a non-cell entering vehicle for transferring a material into a cell, the vehicle comprising bioactive and/or resorbable silicon, and a material to be transferred into a cell. The invention also concerns a vehicle for transferring a material into a cell, the vehicle comprising a sub-micron porous and/or polycrystalline silicon particle.

89. 发明专利

GB0118689D0 Pharmaceutical formulation 未知
公开(公告)号：GB0118689D0
公开(公告)日：2001-09-19
申请号：GB0118689
申请日：2001-08-01
申请人： PSIMEDICA LTD
IPC分类号： G01N33/15 , A61K9/00 , A61K9/12 , A61K9/14 , A61K9/16 , A61K9/48 , A61K33/00 , A61K38/00 , A61K38/22 , A61K39/00 , A61K45/00 , A61K47/04 , A61K47/48 , A61K49/00 , A61M15/00
摘要： The use of microparticles of silicon and particularly resorbable and/or photoluminescent silicon in the preparation of a medicament for nasal or pulmonary delivery. Aerosol formulations and their preparation are also described and claimed. These formulations may be used for example as carriers for pharmaceutical compounds as well as having diagnostic applications.

你已经成功收藏专利！

检索式保存成功!

IPRDB